Platelet inhibition with cangrelor in patients undergoing PCI.

MLA

Harrington, Robert A., et al. “Platelet Inhibition with Cangrelor in Patients Undergoing PCI.” The New England Journal of Medicine, vol. 361, no. 24, Dec. 2009, pp. 2318–29. EBSCOhost, https://doi.org/10.1056/NEJMoa0908628.

APA

Harrington, R. A., Stone, G. W., McNulty, S., White, H. D., Lincoff, A. M., Gibson, C. M., Pollack, C. V., Jr, Montalescot, G., Mahaffey, K. W., Kleiman, N. S., Goodman, S. G., Amine, M., Angiolillo, D. J., Becker, R. C., Chew, D. P., French, W. J., Leisch, F., Parikh, K. H., Skerjanec, S., & Bhatt, D. L. (2009). Platelet inhibition with cangrelor in patients undergoing PCI. The New England Journal of Medicine, 361(24), 2318–2329. https://doi.org/10.1056/NEJMoa0908628

Chicago

Harrington, Robert A, Gregg W Stone, Steven McNulty, Harvey D White, A Michael Lincoff, C Michael Gibson, Charles V Pollack Jr, et al. 2009. “Platelet Inhibition with Cangrelor in Patients Undergoing PCI.” The New England Journal of Medicine 361 (24): 2318–29. doi:10.1056/NEJMoa0908628.